‐Unresectable or metastatic CRC with BRAFV600E mutation‐Priorly treated with BRAF therapy (not including regorafenib) and anti‐EGFR therapy (Cetuximab or panitumumab). This evidence concerns the gene BRAF and colorectal carcinoma.